Propanc Biopharma Awaits FDA Response to Orphan Drug Designation Request for Treatment of Pancreatic Cancer, as PRP Progresses to First-In-Human Studies May 16, 2017
Propanc Biopharma Provides Update on Investigational Medicinal Product (IMP) Manufacture of PRP for First-In-Human Studies May 2, 2017
Propanc Health Group Corporation to Webcast, Live, at VirtualInvestorConferences.com April 6 Apr 3, 2017
Propanc Authorizes Reverse Stock Split and Corporate Name Change to Propanc Biopharma, Inc. Mar 31, 2017
Propanc Successfully Completes Low Dose Group for GLP-Compliant 28-Day Repeat-Dose Toxicity Study Feb 14, 2017
